Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model.

Tim Lenz-HabijanM BroddeB E KehrelC BannewitzK GromannP BhogalM Aguilar PerezH MonstadtH Henkes

Published in: Cardiovascular and interventional radiology (2019)

The pHPC coating significantly reduces thrombogenicity of the p48 FD. This may help to reduce the risk of thromboembolic complications when using these devices. A reduction in antiplatelet therapy may be possible.

Keyphrases

antiplatelet therapy
acute coronary syndrome
percutaneous coronary intervention
internal carotid artery
atrial fibrillation
risk factors
coronary artery disease
middle cerebral artery